<DOC>
	<DOCNO>NCT02333591</DOCNO>
	<brief_summary>GLP-1 agent treatment type 2 diabetes may protective effect cardiovascular system . The mechanism complex seem dual function intact GLP-1 ( 7-36 ) , act GLP-1 receptor , GLP-1 ( 9-36 ) metabolite act independently GLP-1 receptor . Coronary flow reserve ( CFR ) ratio flow coronary artery stress rest reflect coronary microcirculation . Impaired CFR strong predictor poor prognosis cardiovascular disease . The aim study investigate acute effect GLP-1 coronary microcirculation endothelial function adult obesity .</brief_summary>
	<brief_title>Effect Intact GLP-1 ( 7-36 ) GLP-1 Metabolite ( 9-36 ) Coronary Peripheral Vascular Function Adults</brief_title>
	<detailed_description>Several study show beneficial effect glucagon-like-peptide-1 ( GLP-1 ) cardiovascular system . Native GLP-1 secrete L-cells intestine GLP-1 ( 7-36 ) 1 rapidly metabolise ubiquitous enzyme dipeptidyl-peptidase-4 ( DPP4 ) metabolite GLP-1 ( 9-36 ) . However , physiological effect GLP-1 cardiovascular system complex seem dual function intact GLP-1 ( 7-36 ) , act GLP-1 receptor , GLP-1 ( 9-36 ) metabolite act independently GLP-1 receptor . The aim study investigate acute effect intact GLP-1 GLP-1 metabolite coronary microcirculation endothelial function adult . Method 20 adult obesity recruit double-blind randomized cross-over study . The first 10 include adult receive 2½ hour infusion intact GLP-1 ( 7-36 ) together DPP-IV inhibitor 2½ hour infusion saline , two separate occasion . The infusion give randomized order minimum 24 hour washout period . The next 10 include adult receive 2½ hour infusion GLP-1 ( 9-36 ) metabolite 2½ hour infusion saline . These also give randomize order minimum 24 hour washout period . Endothelial function CFR measure one , respectively two , hour infusion . The effect GLP-1 infusion microvascular function evaluate coronary flow reserve ( CFR ) , ratio echocardiographic measure coronary flow velocity LAD adenosine induce myocardial hyperaemia rest . The effect endothelial function assess flow mediate dilation ( FMD ) .</detailed_description>
	<mesh_term>Glucagon-Like Peptide 1</mesh_term>
	<criteria>Age 3570 year BMI &gt; 25 kg/m2 . Central obesity ( measure waist circumference , define ≥ 94cm men ≥ 80 cm woman ) Non smoker ( 6 month abstinent require ) Normal creatinine For fertile woman ; negative pregnancy test use safe anticonception . Speak understand Danish English Mental ability follow understand study Known Diabetes Known hypertension ( untreated hypertension ≤ 160/100 inclusion accept ) Haemoglobin &lt; 6.5 mmol/l Allergy towards Januvia Exenatide , Adenosin Glycerylnitrate Documented significant stenosis leave anterior descend artery ( LAD ) coronary angiography CTangiography regional dysfunction document dipyridamol stressechocardiography . If stress test baseline show significant stenosis patient exclude study . Pregnancy Severe asthma Active cancer , severe comorbidity limited lifeexpectancy , severe hepatic comorbidity , chronic alcohol abuse , atrial fibrillation , chronic previous acute pancreatitis , inflammatory bowel disease .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>